The next chapter for group B meningococcal vaccines
The majority of invasive meningococcal disease (IMD) in the developed world is caused by capsular group B Neisseria meningitidis, however success with vaccination against organisms bearing this capsule has previously been restricted to control of geographically limited clonal outbreaks. As we enter...
Үндсэн зохиолчид: | Wang, N, Pollard, A |
---|---|
Формат: | Journal article |
Хэл сонгох: | English |
Хэвлэсэн: |
Taylor and Francis
2017
|
Ижил төстэй зүйлс
Ижил төстэй зүйлс
-
Group B meningococcal vaccine science and policy
-н: Drysdale, SB, зэрэг
Хэвлэсэн: (2015) -
Group B meningococcal vaccine: Recommendations for UK use
-н: Pollard, A, зэрэг
Хэвлэсэн: (2014) -
Group B meningococcal vaccine: recommendations for UK use.
-н: Pollard, A, зэрэг
Хэвлэсэн: (2014) -
Four component meningococcal capsular Group B vaccine in preterm infants.
-н: Sadarangani, M, зэрэг
Хэвлэсэн: (2017) -
Meningococcal vaccines.
-н: Rüggeberg, J, зэрэг
Хэвлэсэн: (2004)